Browsing Tag
Sebastien Goudreau
1 post
ImmuPharma (AIM: IMM) advances P140 patent and partnering push with new study data and peer-review manuscript in preparation
ImmuPharma's P140 clears UK patent examination as new study data and Bio-Europe partner meetings strengthen the 2026 licensing case. Read the full analysis.